Due to health issues, this site is no longer maintained and will be shut down shortly.

SXTC China SXT Pharmaceuticals, Inc.

We are an innovative pharmaceutical company based in China focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (“TCMP”), which is a type of Traditional Chinese Medicine (“TCM”) that has been processed to be ready for use. TCMP is a type of TCM that has been widely accepted by Chinese people for thousands of years. Over the past decades, TCMP products’ origin, identification, prepared process, quality standard, indication, dosage and administration, precautions, and storage have been well documented, listed and specified in "China Pharmacopoeia“ an official guidance on manufacturing TCMP compiled by the Pharmacopoeia Commission of the Ministry of Health of the People's Republic of China. In recent years, the TCMP industry has enjoyed more rapid growth than any other segment of the pharmaceutical industry primarily due to favorable government policies, as TCMP products do not have to go through rigorous clinical trials before commercialization. We currently sell three types of TCMP products: Advanced TCMP, Fine TCMP and Regular TCMP. Although all of our TCMP products are generic TCMP drugs and we did not change the medical effects of these products in any significant way, these products are innovative in terms of their unconventional administration. The complexity of the manufacturing process is what differentiates these types of products. Advanced TCMP typically is of the highest quality because it requires specialized equipment to manufacture, and has to go through more manufacturing steps to produce than Fine TCMP and Regular TCMP. Fine TCMP is also manufactured with more refined ingredients than regular TCMP.

$0.28  -0.02 (-7.97%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  China
Country of incorporation:  
IPO date:  01/04/2019
Outstanding shares:  2,687,246
Average volume:  243,868
Market cap:   $826,328
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy